人参皂苷-Rg3 的药理作用研究进展

doi:10.3969/j.issn.2095-1396.2017.01.005

摘要/Abstract

摘要： 人参是我国传统名贵中药材，药用历史悠久。人参中生理活性的最主要成分是人参皂苷，其中人参皂苷-Rg3 是一种药用价值极高的中药成分，研究其药理作用，可以为人参皂苷-Rg3 的进一步开发和利用提供理论指导。该文以近年来国内外关于人参皂苷-Rg3 的文献为基础，对其药理作用进行总结和分析。文献报道的药理研究表明，人参皂苷-Rg3 具有抗肿瘤、降低化疗药物的心脏毒性和肾毒性、翻转肿瘤细胞对抗癌药物的多药耐药性、保护中枢神经系统和心血管系统、抗疲劳、降血糖、修复创面等广泛药理作用。

关键词: 人参皂苷-Rg3, 药理作用, 抗肿瘤, 中枢神经系统, 心血管系统

Abstract: Ginseng is a traditional Chinese drug，with a long medicinal history. The main active components of ginseng are the ginsenosides，among which the ginsenoside-Rg3 is a kind of components in ginseng，with higher medicinal value，studying on the pharmacological effects can provide theoretical guidance for further development and utilization of ginsenoside-Rg3. According to domestic and foreign researches reports of ginsenoside-Rg3 in recent years，the pharmacological effects of ginsenoside-Rg3 were summarized and analyzed in this review. The pharmacological studies reported in the literature have indicated that the ginsenoside-Rg3 exhibited various pharmacological activities，such as anti-tumor，reduce the cardiac toxicity and nephrotoxicity of chemotherapy drugs，reverse the multidrug resistance of tumor cells to anticancer drugs，protect the central nervous system and cardiovascular system，anti-fatigue，hypoglycemic effect，repair wound，and other aspects.

Key words: ginsenoside-Rg3, pharmacological activitiy, anti-tumor, central nervous system, cardiovascular system

中图分类号:

R932

苏晓梅，张丹参. 人参皂苷-Rg3 的药理作用研究进展[J]. 神经药理学报, 2017, 7(1): 38-44.

SU Xiao-mei，ZHANG Dan-shen. Research Progress in Pharmacological Activities of Ginsenoside-Rg3[J]. Acta Neuropharmacologica, 2017, 7(1): 38-44.

参考文献

[1] Mar Vergel, Juan J Marin, Purificacion Estevez, et al. Cellular senescence as a target in cancer control[J]. J Aging Res, 2010, 2011(3): 1-13.

[2] Seong Sin, Sung Young Kim, Sung Su Kim, et al. Chronic treatment with ginsenoside Rg3 induces Akt-dependent senescence in human glioma cells[J]. Int J Oncol, 2012, 41(5): 1669-1674.

[3] Claire Louise Allen, Ulvi Bayraktutan. Oxidative stress and its role in the pathogenesis of ischaemic stroke[J]. Int J Stroke, 2009, 4(6): 461-470.

[4] Ding Shi-jie, Li Chun-bao, Cheng Ning-hui, et al. Redox regulation in cancer stem cells[J]. Oxid Med Cell Longev, 2015, 2015: 1-11.

[5] Yoon Ji Choi, Hyun Joo Lee, Kang Dong-wan, et al. Ginsenoside Rg3 induces apoptosis in the U87MG human glioblastoma cell line through the MEK signaling pathway and reactive oxygen species[J]. Oncol Rep, 2013, 30(3): 1362-1370.

[6] Sajani S Lakka, Jasti S Rao. Antiangiogenic therapy in brain tumors[J]. Expert Rev Neurother, 2008, 8(10): 1457-1473.

[7] Sun Cai-xing, Yu Yang, Wang Li-zhen, et al. Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on ratglioma cells both in vivo and in vitro[J]. J Exp Clin Cancer Res, 2016, 35(1): 32-44.

[8] Eun Ji Joo, Jaemoo Chun, Young Wan Ha, et al. Novel roles of ginsenoside Rg3 in apoptosis through downregulation of epidermal growth factor receptor[J]. Chem Biol Interact, 2015, 233: 25-34.

[9] Xie Qi-peng, Wen Huai-kai, Zhang Qiong, et al. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell[J]. Biomed Pharmacother, 2017, 85: 16-21.

[10] Hwa Yeon Sun, Jun Hee Lee, Yong-seok Han, et al. Pivotal roles of ginsenoside Rg3 in tumor apoptosis through regulation of reactive oxygen species[J]. Anticancer Res, 2016, 36(9): 4647-4654.

[11] Liu Tai-guo, Huang Ying, Cui Dan-dan, et al. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice[J]. BMC Cancer, 2009, 9(1): 250-261.

[12] Dong-Gun Kim, Kyung Hee Jung, Da-Gyum Lee, et al. 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin[J]. Oncotarget, 2014, 5(12): 4438-4451.

[13] Zhou Bo, Wang Jian-hua, Yan Zhi-ping. Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma rat model[J]. Onco Target Ther, 2014, 7: 1945-1954.

[14] Zhang Yun, Liu Qing-zhan, Xing Su-ping, et al. Inhibiting effect of Endostar combined with ginsenoside Rg3 on breast cancer tumor growth in tumor-bearing mice[J]. Asian Pac J Trop Med, 2016, 9(2): 180-183.

[15] Bo-Mim Kim, Do-Hee Kim, Jeong-Hill Park, et al. Ginsenoside Rg3 inhibits constitutive activation of NF-κB signaling in human breast cancer (MDA-MB-231) cells: ERK and Akt as potential upstream targets[J]. J Cancer Prev, 2014, 19(1): 23-30.

[16] 彭梦娇, 翟惠, 冯艳华, 等. Rg3通过PI3K/Akt调控MGBA表达促进乳腺癌细胞凋亡的研究[J]. 辽宁医学院学报, 2016, 37(3): 1-11.

[17] Xu Tian-min, Cui Man, Xin Y, et al. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis[J]. Chin Med J, 2008, 121(15): 1394-1397.

[18] 王东辉, 闻春艳. 人参皂苷-Rg3对宫颈癌荷瘤小鼠治疗作用的实验研[J]. 中国妇幼保健, 2016, 31(19): 4046-4048.

[19] Seung Jae Lee, Woo Jin Lee, Sung Eun Chang, et al. Antimelanogenic effect of ginsenoside Rg3 through extracellular signal-regulated kinase-mediated inhibition of micro-phthalmia associated transcription factor[J]. J Ginseng Res, 2015, 39(3):238-242.

[20] Shan Xiu, Tian Li-li, Zhang Yu-mei, et al. Ginsenoside Rg3 suppresses FUT4 expression through inhibiting NF-κB/p65 signaling pathway to promote melanoma cell death[J]. Int J Oncol, 2015, 47(2): 701-709.

[21] Zhang Fei, Li Mao-lan, Wu Xiang-song, et al. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway[J]. Drug Des Devel Ther, 2015, 9: 3969-3687.

[22] Chang Liang, Huo Bing, Lv Ya-lei, et al. Ginsenoside Rg3 enhances the inhibitory effects of chemotherapy on esophageal squamous cell carcinoma in mice[J]. Mol Clin Oncol, 2014, 2(6): 1043-1046.

[23] 张继华, 陈春菊, 宋冬梅, 等. 人参皂甙Rg3对人喉鳞癌裸鼠移植瘤中SIX1、TGF-β、VEGF-C表达的影响[J]. 中药药理与临床, 2016, 32(2): 91-94.

[24] Wang Xiao-ying, Chen Li-li, Wang Ting, et al. Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt[J]. Phytomedicine, 2015, 22(10): 875-884.

[25] Myoung-Sik Han MS, Im-Ho Han, Dahae Lee, et al. Beneficial effects of fermented black ginseng and its ginsenoside 20(S)-Rg3 against cisplatin-induced nephrotoxicity in LLC-PK1 cells[J]. J Ginseng Res, 2016, 40(2): 135-140.

[26] Young Ju Lee, Sangchul Lee, Jin Nyoung Ho, et al. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin resistant bladder tumor cell line[J]. Oncol Rep, 2014, 32(5): 1803-1808.

[27] Sung Su Kim, Sin Seong, Sung Young Kim. Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells[J]. Oncol Lett, 2014, 7(4): 1265-1269.

[28] He Bo, Chen Peng, Yang Jian-yu, et al. Neuroprotective effect of 20(R)-ginsenoside Rg(3) against transient focal cerebral ischemia in rats[J]. Neurosci Lett, 2012, 526(2): 106-111.

[29] 何波, 陈鹏, 龙江, 等. 20(R)-人参皂苷-Rg3对大鼠缺血再灌注后迟发性神经元损伤的保护作用[J]. 时珍国医国药, 2016, 27(1): 35-38.

[30] Tian Jing-wei, Fu Feng-hua, Geng Mei-yu, et al. Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats[J]. Neurosci Lett, 2005, 374(2): 92-97.

[31] Tian Jing-wei, Zhang Shu-min, Li Gui-sheng, et al. 20(S)-ginsenoside Rg3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain[J]. Phytother Res, 2009, 23(4): 486-491.

[32] 陈群伟, 舒琦瑾, 刘清君, 等. 人参皂苷-Rg3对大鼠奥沙利铂神经毒性的保护作用[C]. 重庆: 青年中西医结合肿瘤学术论坛, 2015: 118-127.

[33] Bao Hai-ying, Zhang Jing, Yeo Soo-Jeong, et al. Memory enhancing and neuroprotective effects of selected ginsenosides[J]. Arch Pharm Res, 2005, 28(3): 335-342.

[34] You Zheng-chen, Yao Qi, Shen Jian-hong, et al. Antidepressant-like effects of ginsenoside Rg3 in mice via activation of the hippocampal BDNF signaling cascade[J]. J Nat Med, 2017, 71(2): 367-379.

[35] Zhang Hua-lin, Zhou Zhong-liu, Chen Zi-ming, et al. Ginsenoside Rg3 exerts anti-depressive effect on an NMDA-treated cell model and a chronic mild stress animal model[J]. J Pharmacol Sci, 2017, 134(1): 45-54.

[36] Kyung Hee Lee, In Young Bae, Song I Park, et al. Antihypertensive effect of Korean Red Ginseng by enrichment of ginsenoside Rg3 and arginine-fructose[J]. J Ginseng Res, 2016, 40(3): 237-244.

[37] Cho Y S, Kim C H, Kim H N, et al. Ginsenoside Rg3 inhibits lipopolysaccharide-induced adhesion molecule expression in human umbilical vein endothelial cell and C57BL/6 mice[J]. Pharmazie, 2014, 69(11): 818-822.

[38] Nu Yu-xia, Zhang Peng, Wang Chu, et al. Effect of ginsenoside Rg3 on tyrosine hydroxylase and related mechanisms in the forced swimming-induced fatigue rats[J]. J Ethnopharmacol, 2013, 150(1): 138-147.

[39] Tang Wen-yan, Zhang Yi, Gao Jing, et al. The anti-fatigue effect of 20(R)-ginsenoside Rg3 in mice by intranasally administratio[J]. Biol Pharm Bull, 2008, 31(11): 2024-2027.

[40] Zhang Wen-jing, Zhang Yue, Ma Xian-de, et al. Effects of acupuncturing Pishu combined with Ginsenoside Rg3 on the immune function of rats with chronic fatigue[J]. Int J Clin Exp Med, 2015, 8(10): 19022-19029.

[41] Chen Fang, Chen Yue-wen, Kang Xin-cong, et al. Antiapoptotic function and mechanism of ginseng saponins in rattus pancreatic β-cells[J]. Biol Pharm Bull, 2012, 35(9): 1568-1573.

[42] Soo Lim, Ji Won Yoom, Sung Hee Choi, et al. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model[J]. Metabolism, 2009, 58(1): 8-15.

[43] Min Joo Kim, Young Do Koo, Min Kim, et al. Rg3 improves mitochondrial function and the expression of key genes involved in mitochondrial biogenesis in C2C12 myotubes[J]. Diabetes Metab J, 2016, 40(5): 406-413.

[44] Johan Waden, Carol Forsblom, Lena M Thorn, et al. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes[J]. Diabetes, 2009, 58(11): 2649-2655.

[45] You Jeong Kim, Su Min Park, Hye Sook Jung, et al. Ginsenoside Rg3 prevents INS-1 cell death from intermittent high glucose stress[J]. Islets, 2016, 8(3): 57-64.

[46] Cheng Zhi-qiang, Li Li. Ginsenoside Rg3 ameliorates lipopolysaccharide-induced acute lung injury in mice through inactivating the nuclear factor-κB (NF-κB) signaling pathway[J]. Int Immunopharmacol, 2016, 34: 53-59.

[47] Wang J, Yu X F, Zhao J J, et al. Ginsenoside Rg3 attenuated omethoate-induced lung injury in rats[J]. Hum Exp Toxicol, 2016, 35(6): 677-684.

[48] Fei Hong-qiang, Li Meng-xuan, Liu Wen-jun, et al. Potential lipase inhibitors from Chinese medicinal herbs[J]. Pharm Biol, 2016, 54(12): 2845-2850.

[49] 李静平, 郑永仁, 张燕. 人参皂苷-Rg3对糖尿病大鼠创面修复作用的实验研究[J]. 云南中医中药杂志, 2016, 37(1): 25-28.

[50] 马莉, 李晓静. 人参皂苷-Rg3对兔耳增生性瘢痕TNF-α和IL-β表达的影[J]. 云南中医学院学报, 2016, 39(1): 6-9.